Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11147877 Compositions and methods for treating CNS disorders

Patent 11147877 was granted and assigned to SAGE Therapeutics on October, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111478770

Patent Inventor Names

Francesco G. Salituro0

Gabriel Martinez Botella0

Albert Jean Robichaud0

Boyd L. Harrison0

Date of Patent

October 19, 2021

Patent Application Number

201908200

Date Filed

August 20, 2019

Patent Citations Received

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11147877 Compositions and methods for treating CNS disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API